Clare Chui Ling Sun MD

PubMed

• Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy.
  Christine Gruessner, Adrian Wiestner, Clare Sun
  Leukemia & Lymphoma. 2025-02-19
• 2 citations
  T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
  Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch
  Blood. 2024-08-01
• 1 citations
  Vaccinations in patients with chronic lymphocytic leukemia.
  Elizabeth R Francis, Jennifer Vu, Catherine Ostos Perez, Clare Sun
  Seminars in Hematology. 2024-04-01

Abstracts/Posters

• Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's T...
  Clare Sun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Spatial Genomic Heterogeneity in Chronic Lymphocytic Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Increases the Clonality of TCR Repertoire in Patients with Chronic Lymphocytic Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Partial Reconstitution of Humoral and Cellular Immunity in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CLL Intraclonal Fractions Defined By Time Since Cell Birth/Division Promote a Leukemia-Supportive, Immune-Tolerant Microenvironment By Distinct Mechanisms 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all